• 1
    Yuen VM, Hui TW, Irwin MG, Yuen MK. A comparison of intranasal dexmedetomidine and oral midazolam for premedication in pediatric anaesthesia: a double-blinded randomized controlled trial. Anesthesia and Analgesia 2008; 106: 171521.
  • 2
    Yuen VM, Hui TW, Irwin MG, Yao TJ, Wong GL, Yuen MK. Optimal timing for the administration of intranasal dexmedetomidine for premedication in children. Anaesthesia 2010; 65: 9229.
  • 3
    Talon MD, Woodson LC, Sherwood ER, Aarsland A, McRae L, Benham T. Intranasal dexmedetomidine premedication is comparable with midazolam in burn children undergoing reconstructive surgery. Journal of Burn Care and Research 2009; 30: 599605.
  • 4
    Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000; 93: 38294.
  • 5
    Belleville JP, Ward DS, Bloor BC, Maze M. Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology 1992; 77: 112533.
  • 6
    Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesthesia and Analgesia 2000; 90: 699705.
  • 7
    Petroz GC, Sikich N, James M, et al. A phase I, two-center study of the pharmacokinetics and pharmacodynamics of dexmedetomidine in children. Anesthesiology 2006; 105: 1098110.
  • 8
    Iirola T, Vilo S, Manner T, et al. Bioavailability of dexmedetomidine after intranasal administration. European Journal of Clinical Pharmacology 2011; 67: 82531.
  • 9
    Vilo S, Rautiainen P, Kaisti K, et al. Pharmacokinetics of intravenous dexmedetomidine in children under 11 yr of age. British Journal of Anaesthesia 2008; 100: 697700.
  • 10
    Chrysostomou C, Di Filippo S, Manrique AM, et al. Use of dexmedetomidine in children after cardiac and thoracic surgery. Pediatric Critical Care Medicine 2006; 7: 12631.
  • 11
    Chrysostomou C, Sanchez De Toledo J, Avolio T, et al. Dexmedetomidine use in a pediatric cardiac intensive care unit: can we use it in infants after cardiac surgery? Pediatric Critical Care Medicine 2009; 10: 65460.
  • 12
    Potts AL, Anderson BJ, Warman GR, Lerman J, Diaz SM, Vilo S. Dexmedetomidine pharmacokinetics in pediatric intensive care – a pooled analysis. Pediatric Anesthesia 2009; 19: 111929.
  • 13
    Wolfe TR, Braude DA. Intranasal medication delivery for children: a brief review and update. Pediatrics 2010; 126: 5327.
  • 14
    Henry RJ, Ruano N, Casto D, Wolf RH. A pharmacokinetic study of midazolam in dogs: nasal drop vs. atomizer administration. Pediatric Dentistry 1998; 20: 3216.
  • 15
    Primosch RE, Guelmann M. Comparison of drops versus spray administration of intranasal midazolam in two- and three-year-old children for dental sedation. Pediatric Dentistry 2005; 27: 4018.
  • 16
    Phillips J. Intranasal dexmedetomidine. The Society of Pediatric Sedation: By Society of Pediatric Sedation, April 27, 2010.
  • 17
    Mason KP, Zgleszewski SE, Dearden JL, et al. Dexmedetomidine for pediatric sedation for computed tomography imaging studies. Anesthesia and Analgesia 2006; 103: 5762.
  • 18
    Mason KP, Prescilla R, Fontaine PJ, Zurakowski D. Pediatric CT sedation: comparison of dexmedetomidine and pentobarbital. American Journal of Roentgenology 2011; 196: 1948.
  • 19
    Malviya S, Voepel-Lewis T, Tait AR, Merkel S, Tremper K, Naughton N. Depth of sedation in children undergoing computed tomography: validity and reliability of the University of Michigan Sedation Scale (UMSS). British Journal of Anaesthesia 2002; 88: 2415.